Gujarat Fluorochemicals Limited (NSE:FLUOROCHEM) Released Earnings Last Week And Analysts Lifted Their Price Target To ₹4,624
Investors in Gujarat Fluorochemicals Limited (NSE:FLUOROCHEM) had a good week, as its shares rose 4.9% to close at ₹4,738 following the release of its quarterly results. It was a workmanlike result, with revenues of ₹16b coming in 3.9% ahead of expectations, and statutory earnings per share of ₹20.17, in line with analyst appraisals. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Gujarat Fluorochemicals after the latest results.
After the latest results, the 15 analysts covering Gujarat Fluorochemicals are now predicting revenues of ₹66.3b in 2027. If met, this would reflect a major 25% improvement in revenue compared to the last 12 months. Per-share earnings are expected to jump 55% to ₹87.08. In the lead-up to this report, the analysts had been modelling revenues of ₹64.7b and earnings per share (EPS) of ₹84.21 in 2027. It looks like there's been a modest increase in sentiment following the latest results, withthe analysts becoming a bit more optimistic in their predictions for both revenues and earnings.
See our latest analysis for Gujarat Fluorochemicals
It will come as no surprise to learn that the analysts have increased their price target for Gujarat Fluorochemicals 13% to ₹4,624on the back of these upgrades. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values Gujarat Fluorochemicals at ₹5,750 per share, while the most bearish prices it at ₹3,000. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.
Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. It's clear from the latest estimates that Gujarat Fluorochemicals' rate of growth is expected to accelerate meaningfully, with the forecast 35% annualised revenue growth to the end of 2027 noticeably faster than its historical growth of 5.1% p.a. over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 12% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Gujarat Fluorochemicals to grow faster than the wider industry.
The Bottom Line
The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Gujarat Fluorochemicals following these results. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.
Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have estimates - from multiple Gujarat Fluorochemicals analysts - going out to 2029, and you can see them free on our platform here.
It might also be worth considering whether Gujarat Fluorochemicals' debt load is appropriate, using our debt analysis tools on the Simply Wall St platform, here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.